Drug intelligence / Profile preview

2',3'-dideoxythymidine-5'-monophosphate

Development stage
Preclinical
Modality
Small Molecules
01

Overview

**Description:** 2',3'-Dideoxythymidine‑5'‑monophosphate (ddTMP) is a synthetic pyrimidine nucleotide analog in which the ribose moiety lacks hydroxyl groups at both the 2' and 3' positions. It is structurally related to thymidine monophosphate but differs by these missing hydroxyls. This modification prevents further chain elongation when incorporated into DNA or RNA by polymerases. **Mechanism of Action:** ddTMP acts as a chain terminator during nucleic acid synthesis because its incorporation into DNA or RNA precludes the addition of subsequent nucleotides due to the absence of critical hydroxyl groups required for phosphodiester bond formation. It has been studied primarily as an investigative tool and potential antiviral agent targeting viral polymerases and kinases such as Mycobacterium thymidine monophosphate kinase[8]. Its main use is experimental; it is not approved for clinical use.

Other names
5'-Thymidylic acid, 3'-deoxy-(((2S,5R)-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl)methoxy)phosphonic acid{[(2S,5R)-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy}phosphonic acid[(2S,5R)-5-(5-methyl–2,4-dioxo–3H-pyrimidin–1–yl)oxolan–2–yl]methoxyphosphonic aciddeoxy-thymidine monophosphate
02

Targets

TMPKmt (Mycobacterium tuberculosis thymidylate kinase)

Beyond the preview

Go deeper on 2',3'-dideoxythymidine-5'-monophosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2',3'-dideoxythymidine-5'-monophosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call